Olean Times Herald

SHANGHAI andSUZHOU, China , Dec. 5, 2024 /PRNewswire/ -- Duality Biologics ("DualityBio") today announced first data from a global Phase 1/2a clinical...

PRINCETON, N.J. , SHANGHAI and SUZHOU, China , Dec. 3, 2024 /PRNewswire/ -- Duality Biologics ("DualityBio"), a clinical-stage biotech company focusin...

Adcendo ApS exercises its option to utilize Duality Biologics' platform to further enhance its first-in-class ADC pipeline PRINCETON, N.J. , SHANGHAI ...